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Re: Arguments Regarding the ‘All Autogenous’ Vascular
Access Policy
M.K. Lazarides,* G.S. Georgiadis,
Department of Vascular Surgery, Demokritos University Hospital, Alexandroupolis, Greece.,
We read with interest the article by Sulkowski and
Schutle offering an autogenous approach in all
patients presenting for hemodialysis access creation.1
Unfortunately, the title seems not to correlate with the
text since any native vein either used in situ,
transposed or translocated is termed autogenous and
not homologous.2 There is no doubt that autogenous
AV fistulas are the first choice access for incidence end
stage renal disease (ESRD) patients and the authors
achieved to create such an access in all but one of their
102 patients. However, it seems that their population
was much different than the average ESRD patient.
The mean age of their patients was only 62 years, two
thirds were men and most AV fistulas were used
during the third week after their creation or even
earlier! Interestingly NKF/DOQI suggests first use of
an autogenous access not earlier than one month and
preferably after 3 months.3 The reader of the article has
the impression that the majority of the patients were
young athletic men with healthy veins allowing early
puncture within 3 weeks.
The authors also specify that the success of the
autogenous approach is based in the use of atraumatic
techniques and magnifying lenses, however, it is
generally accepted that the main problem in trying
to create an autogenous fistula is the quality of the
outflow vein. Despite the importance of the preopera-
tive physical examination, which seems that the
authors favour, the cornerstone of the preoperative
evaluation is non-invasive testing in the vascular
laboratory. At least one randomised trial suggested
better success rate for native AV fistulas in patients
with preoperative non-invasive imaging compared
with physical examination alone.4 Additionally, guide-
lines for vascular access monitoring recommend
bimonthly evaluation by access flow measurement
and not twice a year as the authors suggested.3
Monitoring should be followed by appropriate inter-
ventions when necessary. Surgical or endovascular
interventions produce better primary assisted patency
rates when revision is performed on still patent failing
fistulae with stenosis than on thrombosed accesses. It
has also been suggested that the majority of non-
maturing fistulae can be salvaged radiologically.5
Surprisingly not surveillance protocol neither a policy
for non-matured accesses was suggested in the
article’s algorithm, while the maturation failure rate
of radiocephalic fistulas is reported high by various
authors ranging 13–70%.6
Late referral is another point of concern as patients
experienced primary failure had to wait more time for
a new access, however, this interval represents time at
risk for catheter-related complications such as bacter-
aemia; every additional month of maturation time is
associated with a 9% risk of catheter-related bacter-
aemia.7 Subgroups of ESRD patients as those older
than 70-years of age—particularly female—with unfa-
vorable anatomy8 or those on long-term steroids
having poor vascular integrity are especially vulner-
able to primary failure and we believe that in these
cases more liberal use of synthetic grafts is justified,
PTFE is not evil! In elderly patients parameters such as
long-term patency and conservation of proximal
access sites are of minimal importance because of
their limited life expectancy. This is why NKF/DOQI
recommends that at least 50% of access in incident
patients should be autogenous fistulae, and not 90%.
This particular recommendation was unchanged in
the revised guidelines.3 In conclusion, the suggested
algorithm was impressively successful applied in the
given ESRD population. The ‘all autogenous’ policy is
not always possible in a ‘difficult’ older ESRD
population with increased late referral rate, in units
willing to keep permanent catheters’ percentage below
the DOQI limits.
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Prosthetic Grafts Equal Autogenous Fistulas only when
Surgeons Ignore Reports in the Literature
L. Turmel-Rodrigues,*
Vascular Radiology, Clinique St-Gatien, 8 Place de la Cathedrale, 37000 Tours, France,
The article of Fisher and Neale published in the April
2003 issue of the Journal1 is very provocative and
contradicts the most recent trends in vascular access
management such as those expressed in the American
multidisciplinary DOQI-guidelines.2 The importance
given to prosthetic grafts and the little room left for
nephrologists and radiologists by these surgeons are
outdated.
The authors seem happy with their 75% primary
(but only 56% final) rate of autogenous access
placement when others report rates close to 100%.3
These high primary (25%) and final (44%) rates of
prosthetic accesses are easily explained by, first, the
absence of systematic venous imaging when clinical
examination did not show evidence of a usable vein in
either forearm. The authors conclude dogmatically but
do not prove that pre-operative venous imaging before
access creation would not increase their proportion of
autogenous fistulae, which contradicts current litera-
ture and practice.2 Second, the policy of graft place-
ment instead of creation of autogenous upper arm
fistulae when a forearm fistula fails or is deemed not
possible (without any imaging) is not supported by
any comparative study originating from this team but
opposes the literature-supported DOQI guidelines.2,4
Grafts are proven to provide lower patency rates and
to be more expensive, since the prosthesis and
revisions have a cost. Moreover, they preclude future
creation of upper arm autogenous fistulae since such
grafts invariably result in greater or lesser degrees of
stenosis of the elbow veins. The ‘site and type of the
next best access (after forearm fistulae) is less clear…’
only in their mind. Third, the creation of a prosthetic
graft in the non-dominant arm for self-cannulation
when an autogenous fistula is feasible in the dominant
arm is even more shocking since the long-term
patency of the access is sacrificed for the apparently
short-term and debatable comfort of self-cannulation.
The authors are not convincing and shoot themselves
in the foot when they conclude that a ‘radiocephalic
fistula provides the ideal access’. Their minds and
their strategy are obviously confused.
Concerning secondary patency rates for autogenous
fistulae, the authors express a brief, personal and
scornful judgement about the value of interventional
radiology but they omit to discuss the recent literature.
First, interventional radiology has been proven
capable of saving a high proportion of immature
fistulae, especially by dilatation of short and long
stenoses located far from the anastomosis on the artery
or on the vein.5,6 The 22% failure rate of the authors’
autogenous fistulae at 6 months would significantly
decrease if they referred these fistulae to a dedicated
radiologist. Second, a very high proportion (90%) of
thrombosed mature forearm autogenous fistulae can
be reopened durably by endovascular techniques,7
whereas, surgical results are much poorer, and some
surgical teams therefore do not even try to recover
them.8,9 The authors’ secondary patency rates for
autogenous fistulae would also be clearly improved if
thrombosed fistulae were referred to a dedicated
interventional radiologist, and they would clearly
surpass grafts. In addition, the authors explain ‘that
there was no policy of routine screening of accesses’,*Address: Dr L.Turmel-Rodrigues, Vascular Radiology, Clinique St-
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